CV #13(B): More On Who Theresa Tam Really Is

1. Other Articles On CV “Planned-emic”

The rest of the series is here. Many lies, lobbying, conflicts of interest, and various globalist agendas operating behind the scenes. The Gates Foundation finances: the World Health Organization, the Center for Disease Control, GAVI, ID2020, John Hopkins University, Imperial College London, the Pirbright Institute, the British Broadcasting Corporation, and individual pharmaceutical companies. Also: there is little to no science behind what our officials are doing; they promote degenerate behaviour; the Australian Department of Health admits the PCR tests don’t work; the US CDC admits testing is heavily flawed; and The International Health Regulations are legally binding. See here, here, and here.

2. Important Links

(1) https://www.canada.ca/en/public-health/corporate/organizational-structure/canada-chief-public-health-officer/biography.html
(2) http://archive.is/Zk6X5
(3) https://rclogin.royalcollege.ca/webcenter/portal/rcdirectory_en/RCDirectorySearch?searchText=Tam%2C+Wing-Sze+Theresa+Ottawa%2C+Ontario%2C+Canada+%28Infectious+Diseases%2C+Pediatrics%29
(4) http://archive.is/8rBVY
(5) https://www.cpso.on.ca/
(6) https://doctors.cpso.on.ca/DoctorDetails/Tam-Wing-Sze-Theresa/0162772-74243#PracticeInformation
(7) https://archive.is/U1RSg
(8) https://www.canada.ca/en/public-health.html
(9) https://archive.is/C5r5z
(10) https://www.who.int/about/who_reform/emergency-capacities/oversight-committee/theresa-tam/en/
(11) https://archive.is/BFM3k
(12) https://www.who.int/about/who_reform/emergency-capacities/oversight-committee/members/en/
(13) https://archive.is/Qdi7Y
(14) https://www.who.int/about/who_reform/emergency-capacities/oversight-committee/walid-ammar/en/
(15) https://archive.is/0Mo2x
(16) https://www.who.int/about/who_reform/emergency-capacities/oversight-committee/hiroyoshi-endo/en/
(17) https://archive.is/sckoV
(18) https://www.who.int/about/who_reform/emergency-capacities/oversight-committee/geeta-rao-gupta/en/
(19) https://archive.is/9Z6R3
(20) https://www.who.int/about/who_reform/emergency-capacities/oversight-committee/jeremy-konyndyk/en/
(21) https://archive.is/o2zTK
(22) https://www.who.int/about/who_reform/emergency-capacities/oversight-committee/malebona-precious-matsoso/en/
(23) https://archive.is/WItki
(24) https://www.who.int/about/who_reform/emergency-capacities/oversight-committee/felicity-harvey/en/
(25) https://archive.is/cmouH

3. Constructing A Timeline

Unfortunately, there is very little information available on her. No date of birth, or place of birth beyond “growing up in Hong Kong”. Even at the schools she claims to have completed, there is no searchable information. One would think they would happy to boast about the accomplishments of their alumnus.

The following credential dates are from the College of Physicians and Surgeons of Ontario, but it doesn’t look like Tam has actually practiced medicine at all. There are publications with her name on it, but the rest of her past is a mystery.

1965 – Tam is born in HK (source: Wikipedia)
1989 – U of Nottingham medical degree (CPSO profile)
1996 – U of Alberta pediatric residency completed (CPSO profile)
1997 – UBC fellowship in infectious diseases (CPSO profile)
1999 – Independent Practice Certificate issues (CPSO profile)

In her CPSO profile, Tam claims not to have used any other names, which would contradict speculation that she once went by the name “Tan Yongshi”.

4. Tam’s CPSO Profile Page

The information here can be found at the College of Physicians and Surgeons of Ontario, (CPSO), the board which licenses doctors. The profile lists “EDUCATION” as coming from the University of Nottingham (in the UK) in 1989. Yes, it was followed up with the College of Physicians and Surgeons that it referred to a medical degree. However, no undergraduate degree is listed.

It also lists finishing a University of Alberta pediatric residency in June 1996. Severn years? That seems to be a particularly long time to finish, so what was she doing in the meantime?

The fellowship in the University of British Columbia in pediatric infectious diseases was finished in September 1997.

What’s interesting though is that in researching these schools: Nottingham, UAlberta and UBC, there is no mention of Theresa Tam at all. Once would think that a graduate who is not “Canada’s top doctor” would warrant special attention and adoration. But there isn’t any mention of her at all.

It also states:

First certificate of registration issued: Independent Practice Certificate

However, Tam was getting into government around that time. It doesn’t look like she ever practiced — ANYWHERE. Yet she has become “Canada’s Top Doctor”. She graduated medical school in 1989 and never got a license to practice until a decade later?

5. No Practice Information In Profile

Dr. Theresa Tam was named Canada’s Chief Public Health Officer on June 26, 2017. She is a physician with expertise in immunization, infectious disease, emergency preparedness and global health security.

Dr. Tam obtained her medical degree from the University of Nottingham in the U.K. She completed her paediatric residency at the University of Alberta and her fellowship in paediatric infectious diseases at the University of British Columbia. She is a Fellow of the Royal College of Physicians and Surgeons of Canada and has over 55 peer-reviewed journal publications in public health. She is also a graduate of the Canadian Field Epidemiology Program.

Dr. Tam has held several senior leadership positions at the Public Health Agency of Canada, including as the Deputy Chief Public Health Officer and the Assistant Deputy Minister for Infectious Disease Prevention and Control. During her 20 years in public health, she provided technical expertise and leadership on new initiatives to improve communicable disease surveillance, enhance immunization programs, strengthen health emergency management and laboratory biosafety and biosecurity. She has played a leadership role in Canada’s response to public health emergencies including severe acute respiratory syndrome (SARS), pandemic influenza H1N1 and Ebola.

Dr. Tam has served as an international expert on a number of World Health Organization committees and has participated in multiple international missions related to SARS, pandemic influenza and polio eradication.

Again, it doesn’t appear from this that Theresa Tam has ever actually practiced medicine. Her first authorization for independent practice was issued in 1999, and she has been in various Government roles for 20 years now.

To get even stranger, it appears that the profile provided here is a cut and paste equivalent of the World Health Organization profile for Tam.

6. Identical Photo/Profile With WHO

Dr. Theresa Tam was named Canada’s Chief Public Health Officer on June 26, 2017. She is a physician with expertise in immunization, infectious disease, emergency preparedness and global health security.

Dr. Tam obtained her medical degree from the University of Nottingham in the U.K. She completed her paediatric residency at the University of Alberta and her fellowship in paediatric infectious diseases at the University of British Columbia. She is a Fellow of the Royal College of Physicians and Surgeons of Canada and has over 55 peer-reviewed journal publications in public health. She is also a graduate of the Canadian Field Epidemiology Program.

Dr. Tam has held several senior leadership positions at the Public Health Agency of Canada, including as the Deputy Chief Public Health Officer and the Assistant Deputy Minister for Infectious Disease Prevention and Control. During her 20 years in public health, she provided technical expertise and leadership on new initiatives to improve communicable disease surveillance, enhance immunization programs, strengthen health emergency management and laboratory biosafety and biosecurity. She has played a leadership role in Canada’s response to public health emergencies including severe acute respiratory syndrome (SARS), pandemic influenza H1N1 and Ebola.

Dr. Tam has served as an international expert on a number of World Health Organization committees and has participated in multiple international missions related to SARS, pandemic influenza and polio eradication.

Sound familiar? It is a cut-and-paste equivalent of what is listed in the Canadian profile. Lazy writing, or is she just serving 2 masters?

7. WHO Committee Tam Serves On

PURPOSE 1. The purpose of the Independent Oversight and Advisory Committee (the Committee”), for the WHO Health Emergencies Programme (“the Programme”), established by the Director-General, is to provide oversight and monitoring of the development and performance of the Programme, guide the Programme’s activities, and report its findings through the Executive Board to the Health Assembly. The Committee will advise the Director-General on issues within its mandate. Reports of the Committee will be shared with the Secretary General of the United Nations and with the United Nations’ InterAgency Standing Committee.

WHO.independent.advisory.committee

Tam is in the obvious conflict of interest in both being:
(a) Canada’s Chief Public Health Officer;
(b) serving on this WHO Committee

So does she serve Canada, or the World Health Organization?

Dr Geeta Rao Gupta has over 20 years of experience in international development programming, advocacy and research with UNICEF.

Prior to her appointment as Deputy Executive Director (Programmes), Dr Rao Gupta served as a senior fellow at the Bill and Melinda Gates Foundation from 2010 to 2011. She acted as the senior adviser to the Global Development Programme on the strategic direction and management of a cross-cutting range of issues and projects.

One of the WHO Committee Members that Tam works with was previously a senior fellow at the Bill and Melinda Gates Foundation. Would be interesting to ask her take on mass vaccinations. Now, let’s see who else is on the Committee.

Prior to his appointment, Mr Konyndyk worked for Mercy Corps, a global relief and development organization, as its Director of Policy and Advocacy. From 2008 to 2013, he led high-level strategic outreach to governments, donors, the UN, and other partners with a focus on resilience and humanitarian responses to Sudan, Syria, and the Horn of Africa. From 2003 to 2008, he served as the American Refugee Committee’s Country Director in South Sudan, Uganda, and Guinea, designing and leading humanitarian responses in conflict and post-conflict settings. Mr Konyndyk earlier served as a Refugee Officer with the US Department of State’s Bureau of Population, Refugees, and Migration where he managed the Bureau’s portfolio for the Balkans. In addition, he led non-governmental organization relief programmes in Kosovo and Albania following the Kosovo refugee crisis.

For those not familiar, Mercy Corps is an NGO who aims to flood the West with migrants and refugees from Africa and the Middle East.

8. Pharma Funding World Health Org., 2017

WHO.Contributions2017Listings

Note: this is by no means an exhaustive list. However, it should provide some insight as to who is funding the World Health Organization, and give a hint as to what the agenda is.

From Schedule 2:

Institution Amount of Money
Bill & Melinda Gates Foundation $324,654,317
World Bank $145,568,331
GAVI Alliance $133,365,051
United Nations Development Programme (UNDP) $18,251,940
Vital Strategies $10,647,550
GlaxoSmithKline (GSK) $7,365,666
Hoffmann-La Roche and Co $6,628,090
Gilead Sciences Inc. $3,124,450
Merck Sharp and Dohme Chibret $1,652,226
Bayer AG $1,158,060
Rockefeller Foundation $748,945
Merck $510,000
Novartis $500,000
International Organization for Migration (IOM) $332,290
Kitasato Daiichi Sankyo Vaccine Co., Ltd(PVS) $220,155
Path Vaccine Solutions(PVS) $294,582
Fluart Innovative Vaccines Ltd. $73,645
Johns Hopkins Bloomberg School of PH $88,069
Path Vaccine Solutions (PVS) $73,385
Open Society Institute Budapest Foundation $55,000
Int’l Fed. of Pharmaceutical Manufacturers Ass’n $50,000

The Bill & Melinda Gates Foundation is the biggest individual donor (excluding nations). Geeta Rao Gupta is a former Senior Fellow at the Gates Foundation. She is also one of the people on the World Health Org. Committee that Theresa Tam works on.

While Tam is “supposed” to be representing the interests of Canadians, her other employer, the World Health Organization, receives large funding from:

  • Bill & Melinda Gates Foundation
  • World Bank
  • GAVI Alliance (Gates funded
  • The Pharma lobby

Side note: The UN Development Program is helping to fund the International Vaccine Institution (which partners with VIDO-InterVac at the University of Saskatchewan). Gates and GAVI help fund that too.

Can it be any surprise that Tam sees mass vaccination as the solution to this so-called “pandemic” in Canada? After all, it’s what her employers want to see happen. And this is hardly the only time this has happened. Certainly individual countries do make significant contributions to the WHO, but the pharma lobbying can’t be ignored.

9. Pharma Funding World Health Org., 2018

Also worth a look is the 2018 statement of contributions.
WHO.Contributions.Statement.2018

From Schedule 2:

Institution Amount of Money
Bill & Melinda Gates Foundation $228,970,196
GAVI Alliance $158,545,964
World Bank $20,556,661
UNITAID $19,688,301
Global Fund to Fight AIDS, TB, Malaria $14,769,596
Hoffmann-La Roche and Co., Ltd $6,624,600
United Nations Population Fund (UNFPA) $6,504,848
GlaxoSmithKline (GSK) $5,482,827
Medimmune $2,086,169
KNCV Tuberculosis Foundation $2,045,388
Merck & Co., Inc $1,184,398
Novartis $500,000
Kitasato Daiichi Sankyo Vaccine Co., Ltd $294,427
Islamic Development Bank $200,000
World Hepatitis Alliance $200,000
SK Bioscience $122,678
Fluart Innovative Vaccines Ltd. $73,607
Int’l Fed. of Anthroposophic Medical Ass’s $50,000
Takeda Pharmaceuticals International GmbH $19,702

Again, this is nowhere near everyone who contributes to the World Health Organization. However, these are some of the parties who fund it. And Theresa Tam sits on this committee, at the same time she claims to be acting in the best interests of Canadians.

10. Tam A WHO Veteran

How international health emergencies are handled holds lessons for Canadian public health on a range of fronts, from infectious diseases to opioid misuse. That’s the view of Dr. Theresa Tam, who became Canada’s Chief Public Health Officer on an interim basis when Dr. Gregory Taylor retired in December 2016. A competition now underway will determine who will eventually fill the spot, but neither the Privy Council Office, which appoints the position, nor the Public Health Agency of Canada (PHAC) has provided a timeline.

Tam has served on three World Health Organization (WHO) emergency committees: Ebola, Middle East respiratory syndrome (MERS) and poliovirus. Emergency committees are convened under the International Health Regulations (IHR) to decide whether disease outbreaks constitute “public health emergencies of international concern” and what measures should be taken to deal with them. Canada has had members on all six of the emergency committees established since the IHR came into force in 2007.

Tam served on several WHO Committees in the 2000’s, and was already “considered a veteran” when appointed to the current role. A Google Scholar search will come up with publications in her name, but they are in the last 20 years or so.

Still it doesn’t help determine what she was doing prior to 2000. Very little information available for the early years.

11. Who Is Theresa Tam Really?

It’s difficult to say. Beyond some very limited information available online, there is next to nothing on her past and early years. Her profile states “growing up in Hong Kong”, and “born in 1965”, yet provides no details.

The schools Tam graduated from don’t have any searchable information on her, which is extremely odd, given her high profile. She graduated medical school in 1989 but doesn’t appear to have obtained a license until 1999. Tam then spent the next 20 years in various Government public health roles, and it seems not to have practiced medicine at all.

Tam did co-author a 2006 report (see CV #12) recommending that vaccination be available to the entire population, and that surveillance apparatus be in place. In fact, she co-authored many research papers in the 2000s. She also participated in the 2010 film “Outbreak” and talked about putting tracking bracelets on, and forced quarantine. Tam spend years in various World Health Organization roles, which is a serious conflict of interest.

While acting as Canada’s Chief Public Health Officer, she sits a World Health Organization Committee. She is part of that Committee along with an ex-Gates Foundation operative. The WHO gets a substantial amount of funding from:

  • Bill & Melinda Gates Foundation
  • World Bank
  • GAVI Alliance (Gates funded
  • The Pharma lobby

In fact, if you read through the previous articles in the series, you will see that a lot of the parties funding WHO (GAVI, GlaxoSmithKline, etc…) are the same ones lobbying the Provinces and Federal Government in Canada. In some sense it “isn’t” a conflict of interest, as Tam’s employers are funded by same special interest groups.

Is Theresa Tam even a Canadian citizen? When did she arrive? There’s no specific information available to the public. She’s like a ghost.

CV #12: Pandemic Report From 2006 Recommends Surveillance And Total Vaccinations

As of late January, 2020, Theresa Tam saw very little risk to Canadians, and that human to human transmission was not a threat

1. Other Articles On CV “Planned-emic”

The rest of the series is here. Many lies, lobbying, conflicts of interest, and various globalist agendas operating behind the scenes. The Gates Foundation finances: the World Health Organization, the Center for Disease Control, GAVI, ID2020, John Hopkins University, Imperial College London, the Pirbright Institute, the British Broadcasting Corporation, and individual pharmaceutical companies. Also: there is little to no science behind what our officials are doing; they promote degenerate behaviour; the Australian Department of Health admits the PCR tests don’t work; the US CDC admits testing is heavily flawed; and The International Health Regulations are legally binding. See here, here, and here.

2. Important Links

(1) https://twitter.com/i/status/1221242779923374081</a
(2)
https://en.wikipedia.org/wiki/Theresa_Tam
(3) http://archive.is/e9jwT
(4) Translated Article
(5) https://www.longwoods.com/articles/images/Canada_Pandemic_Influenza.pdf
(6)Tam.Canada_Pandemic_Influenza.2006.report
(7) https://www.theglobeandmail.com/canada/article-ottawa-had-a-playbook-for-a-coronavirus-like-pandemic-14-years-ago/
(8) http://archive.is/oBxhf

3. Is Theresa Tam Really Tan Yongshi?

Also check out this link, from an article that identifies Tam as “Tan Yongshi”. Credit is due to Christina Forbes for catching this is the first place.

As the chief health officer, what are the negligent duties that Ms. Tan Yongshi should step down from? In general, there are five aspects. First of all: she should be vigilant about the lack of the new crown epidemic. Wuhan was closed on January 23, and the first patient appeared in Canada on January 25. On January 30, WHO declared the new coronary pneumonia as a public health emergency, and the United States announced the closure of China the next day. At that time, the Chinese community understood the seriousness of the virus and appealed to the government to be vigilant, but Tan was indifferent to it and repeatedly emphasized that Canada’s risk was very low, thus missing the best time for prevention and control. After the closure of the United States, because Canada did not take measures, many travelers detoured to Canada to the United States. During their stay in Canada, they planted hidden dangers for the spread of the virus.

Second: Due to the contempt of Tan Yongshi and the government, the Canadian border epidemic prevention and isolation measures are useless. Among the countries in the world, Canada is the only country that has no airport temperature measurement since the outbreak. In the early stage of the epidemic, all entrants were only verbally asked whether they came from the epidemic area, and there was no requirement for isolation. Nevertheless, most Chinese are consciously isolated for 14 days. In the middle of the outbreak, although the government made a 14-day quarantine request, there was no compulsory follow-up measure. Now that the epidemic has almost peaked, the government has proposed coercive measures, but there is no guarantee of law enforcement, because the RCMP responsible for law enforcement has not issued a ticket. If it is said that Trudeau did this based on Ms. Tan ’s opinion, then Tan did not warn against the strengthening of airport detection and isolation, which is her negligence.

There appear to be translation issues, as it switches names several times. Nonetheless, it does refer to Theresa Tam as Tan Yongshi.

It would be nice to nail this down for certain. Should any reader come across this and have more information, please share. Personally, it would be nice to have more material than: (1) a Wikipedia page; and (2) an article from Google Translate.

To play some devil’s advocate, even if this is the case, it may be attempt to simply adopt a more English sounding name. Many people have done it before.

4. Critique Of 2006 Epidemic Plan

A 2006 report co-written by Dr. Theresa Tam – now the face of Canada’s COVID-19 response – predicted our current situation, and the steps needed to get out of it, with eerie accuracy. But the actual response has been very different

A pandemic sweeps across Canada in one or two months. It is spread not only by the sick, but by people who show no symptoms. There are shortages of medical supplies and the health system struggles to keep up. The peak won’t come for months, and it will be accompanied by a surge in deaths. Soon after, the country will brace for a second wave.

All of this is now true for the COVID-19 crisis, but the aforementioned scenario – a warning – comes from a 2006 federal report on pandemic preparedness. Fourteen years later, its words are eerily accurate.

Despite the prescience of such warnings, Canada and many other governments around the world significantly underestimated the severity of the coronavirus.

As recently as late January, federal officials, including Dr. Tam, said the threat of a major outbreak in Canada was very low, that measures such as travel restrictions weren’t needed, and that the risk of the virus being spread by people without symptoms was highly unlikely.

The article goes on to criticize the Federal Government’s lack of preparedness in many different ways, and in great detail. To their credit, the Globe & Mail is pretty thorough in many ways.

But what they missed in their critique is the propaganda elements within the 2006 report. They may be subtle, but they are there.

5. Contents Of 2006 Report

For vaccine program planning purposes, it is important to be prepared to immunize 100% of the population; however, the actual proportion of the population that will voluntarily seek vaccination will depend on public perception of the risk and the severity of the disease. Therefore, the demand, which will manifest as clinic attendance, will likely vary among jurisdictions and within each jurisdiction as the pandemic evolves. Previous experience with outbreak-related immunization clinics indicates that it would be prudent to prepare for an initial demand of 75% of the target population. It is recommended that planning activities also focus on delivering a two dose program to ensure that the public health response is ready to deal with this possibility.

Tam.Canada_Pandemic_Influenza.2006.report
If you go to section 2.2 (page 60 in the 550 page pdf file), it does point out an interesting fact: that the amount of people who will voluntarily take a vaccination depends on the public perception of risk.

Therefore: one can reasonably conclude from this, if the goal is mass vaccination of the public, it is necessary to get them afraid, and keep them afraid.

The Canadian Pandemic Influenza Plan for the Health Sector (the Plan) consists of an introduction and a background section, followed by the preparedness, response and recovery sections, which are consistent with the general principals of emergency response. Each section aims to assist and facilitate appropriate planning for the health sector at all levels of government for the next influenza pandemic. The Plan and the annexed guidelines, checklists and other documents were developed to assist all jurisdictions with the main components of health sector planning, including surveillance, vaccine programs, use of antivirals, health services, public health measures and communications. The most effective public health intervention to mitigate the impact of a pandemic is through immunization with an effective vaccine against the novel virus, and, to a lesser extent, through the use of antiviral drugs. In addition, comprehensive planning requires that appropriate surveillance capacity is in place, and that the health sector, emergency services and communities as a whole are informed and equipped to deal with a pandemic.

This is from the PREFACE (page 21 in 550 page pdf file). It states that the best solution is a vaccine against the novel virus, and that antivirals are a lesser option. Okay, so every time there is a “novel” virus, we need to break out the vaccine testing?

The preface also states that an appropriate surveillance capacity is needed. Perhaps it could be forcing people to wear bracelets, as Theresa Tam/Tan Yongshi suggests.

The components of the 2004 edition of the Plan included surveillance, vaccine programs, antivirals, health services, emergency services, public health measures and communications. In this edition of the Plan, the emergency services component has been removed; it is now addressed as part of the preparedness for overall emergency management and coordination.

Federal, provincial, territorial and local planners are encouraged to consider the psychosocial implications of pandemic influenza when developing their plans for preparedness and response activities. It is anticipated that a component focusing on psychosocial issues will be added to future versions of the Plan.

Section 2.0 (page 54 of the 550 page pdf) openly states that surveillance and vaccine programs are to be prominent portions of this plan. It seems nothing has changed.

Jurisdictions need to be prepared to rapidly implement or modify enhanced surveillance activities. For the purpose of informing public health risk assessment and response activities, a coordinated and rapid epidemiological investigation that includes the collection, collation and analysis of detailed epidemiological, laboratory and clinical data is required. Further, rapid sharing of data and efficient communication at all levels of government are critical for facilitating a coordinated response.

At the federal level, regular environmental scanning for the detection of potentially significant ILI is conducted using official information sources for influenza surveillance (e.g. World Health Organization [WHO] and government influenza surveillance programs from other countries) and unconfirmed reports from early warning systems (e.g. ProMed and other media scanning software, such as the Global Public Health Intelligence Network).

On an ongoing basis, the newly created national expert Working Group for Vaccine Preventable and Respiratory Infections Surveillance (VPRIS-N) will be assessing surveillance systems and making recommendations for enhancements and improvements for the Interpandemic, Pandemic Alert and Pandemic Periods. Recommendations from this group are being refined on an ongoing basis; current recommendations are included in Annex N, Pandemic Influenza Surveillance Guidelines.

The report in this focuses on the need for new surveillance methods (page 56 of 550 page pdf). While avoiding specifics, it acknowledges that expanding it would be greatly beneficial.

Because surveillance data will drive the pandemic response, it is important that physicians and other health care workers are educated and updated on an ongoing basis about the importance of ILI surveillance as well as their roles in the system. Surveillance systems must be established in advance of a pandemic because there will be little time to augment capacity at the time of a pandemic. At the time of a pandemic, surveillance and laboratory-testing capacity will be reduced (e.g. due to staff absenteeism and potential supply shortages) compared with pre-pandemic periods; only streamlined, resource-efficient systems will continue to function. Special study protocols if required (e.g. to determine epidemiology or to investigate reported adverse events following immunization) at the time of a pandemic must be developed and pretested during the pre-pandemic period, recognizing that refinements may be necessary at the time of a pandemic.

However, on the next page, the report suggests that surveillance systems must be established well in advance, as it may not be possible later. Again, avoiding specifics about what that surveillance would be about?

Vaccination of susceptible individuals is the primary means to prevent disease and death from influenza during an epidemic or pandemic. The National Advisory Committee on Immunization (NACI) produces annual recommendations on the use of influenza vaccine in persons who are most at risk for influenza or those who could spread influenza to persons at greatest risk. These interpandemic recommendations are published annually in the Canada Communicable Disease Report. In the event of a pandemic, PIC, which includes representation from NACI, will provide recommendations to F/P/T immunization programs on the development, production and use of the pandemic vaccine, and priority groups for immunization. Efforts should be made to encourage all jurisdictions to adopt the national recommendations on priority groups at the time of a pandemic in order to facilitate equitable access and consistent messaging.

That’s from page 57. “Consistent messaging”??? Does that mean that government officials should keep their talking points consistent in order to prevent the public from picking out contradictions?

From page 59 of the report. In case you were wondering “recombinant vaccines” are ones that are made up of combined genetic material. Think of it as a Franken-vaxx.

Vaccines, when available, will be the primary public health intervention during a pandemic. However at the start of the pandemic, vaccines may not be available as soon as required and two doses of vaccine may be necessary to achieve an adequate immune response. Antivirals (anti-influenza drugs) are effective for both treatment and prophylaxis of annual influenza. These drugs were not available during past pandemics, but are expected to be effective against pandemic strains of the influenza virus. Antivirals will likely be the only virus-specific intervention during the initial pandemic response. Protection afforded by antivirals is virtually immediate and does not interfere with the response to inactivated influenza vaccines.

From page 61. Vaccines are to be the primary defence against an outbreak.

During a pandemic, antiviral strategies should use all the types of effective anti-influenza drugs that are available to Canadians, and should be adaptable to changing disease epidemiology and vaccine availability. If the novel virus is found to be susceptible to amantadine, which is not currently part of the National Antiviral Stockpile, it is recommended that amantadine be used for prophylaxis (not treatment) only. Oseltamivir could be used for both treatment of cases and prophylaxis. The efficacy of oseltamivir and amantadine are approximately equal for the treatment of cases infected with sensitive strains; however, amantadine is recommended exclusively for prophylaxis to minimize the development of amantadine resistance (which would render the drug ineffective) during the pandemic. The timing of the use of antivirals during a pandemic should be guided by local surveillance data.

From page 63. We think antivirals are okay, but only as long as they don’t interfere with vaccines at some point in the future.

This 550 page report is too long to go through in a single article. However, it’s morbid how much: (a) surveillance; and (b) vaccines are woven into the entire report. It reads as if the entire research was to set up a police state and drug everyone.

The Globe & Mail article referenced in the last section complained that the Federal Government was grossly unprepared considering this 2006 report. While true in some sense, the G&M authors apparently didn’t bother to actually read this report before publishing their article.

6. Vaxx/Surveillance Planned From 2004?

How long exactly has this been going on for? How long has this plan been in the works for? It can’t just be a series of random and unrelated events. Has it been going on for much longer that 16 years?

  • In 2004, this research begins.
  • In 2006, it is released. It recommends heavy surveillance, and vaccinations for everyone.
  • In 2010, Theresa Tam/Tan Yongshi participated in the film “Outbreak Of An Epidemic”, which depicted a fictional simulation of the Federal Government responding to a pandemic.
  • In 2017, Raj Saini (who is pharma lobbied), introduced M-132, to fund drug research and get drugs out to Canadians, and to the world at large.
  • In October 2019. Event 201 took place. This was the Gates-involved simulation which would see tens of millions of people die in a computer model of an outbreak.

Again, credit to Civilian Intelligence Network for digging up the 2010 film. The whole thing reads like a giant dress rehearsal for the actual shut down.

An interesting observation in the report: voluntary vaccinations will happen in much larger numbers if people feel the threat is real and imminent. That may explain all the dire warnings coming from the government.

As for Theresa Tam, is that her real name? To be fair, even if true, it could be to adopt a more “Anglo” sounding name. Still, it would be nice to know.

CV #13: Corona Planned-emic; Lobbying; Deleted Resources; CL Listings; Theresa Tam, Canada’s “Hoaxer Zero”


Start clip at 56:50. It will give you chills.

Thank you to Civilian Intelligence Network for digging up the film. In what can only be described as predictive programming, or a trial run, Theresa Tam “Canada’s top Doctor” takes part in a 2010 film about a fictional epidemic in Canada. Doesn’t get much more premeditated than shooting a film a decade in advance.

In the film (56:50 to 57:50) Tam talks approvingly (seeming almost giddy) about being able to enforce mandatory quarantines, using tracking bracelets, and only “worry later” about questions of an overreach. It’s difficult to make the clip look worse than it actually is. Seems that life is now imitating art.

And on a more petty note: there is something not quite human about those eyes.

1. Other Articles On CV “Planned-emic”

The rest of the series is here. Many lies, lobbying, conflicts of interest, and various globalist agendas operating behind the scenes, obscuring the “Great Reset“. The Gates Foundation finances: the WHO, the US CDC, GAVI, ID2020, John Hopkins University, Imperial College London, the Pirbright Institute, the BBC, and individual pharmaceutical companies. Also: there is little to no science behind what our officials are doing; they promote degenerate behaviour; the Australian Department of Health admits the PCR tests don’t work; the US CDC admits testing is heavily flawed; and The International Health Regulations are legally binding. See here, here, and here. The media is paid off, and our democracy is thoroughly compromised, as shown: here, here, here, and here.

2. Other Important Links

(1) https://www.publicsafety.gc.ca/cnt/rsrcs/lbrr/ctlg/dtls-en.aspx?d=PS&i=27125339
(2) http://archive.is/WF84K
(3) https://www.who.int/about/who_reform/emergency-capacities/oversight-committee/theresa-tam/en/
(4) http://archive.is/BFM3k
(5) https://www.canada.ca/en/public-health/corporate/organizational-structure/canada-chief-public-health-officer.html
(6)http://archive.is/dkXMK
(7) https://magamedia.org/2020/04/21/breaking-it-is-being-reported-that-the-gates-foundation-world-health-organization-and-wuhan-institute-of-virology-have-all-been-hacked-and-thousands-of-emails-passwords-and-documents-have-been-l/
(8) http://archive.is/m1Gm9
(9) CLICK HERE, for GAVI’s deleted site, archives.

https://twitter.com/SomeBitchIKnow

https://civilianintelligencenetwork.ca/

3. Lobbying Needs To Be Addressed

Several articles in this series cover the lobbying by Bill Gates and other pharmaceutical companies in general. This is rampant at the Provincial and Federal levels, and goes on outside of Canada as well.

The reason for this focus is to give context. One can’t understand why politicians are pushing the vaccine agenda without realizing how much influence peddling goes on behind the scenes. Big pharma, to a large degree, is pulling the strings of our public officials. Hence the obsession with getting everyone vaccinated.

It must also be addressed that Bill Gates (among others), is promoting a depopulation agenda. While developing and pushing vaccines under the guise of promoting global health, Gates has spoken many times about how the world has too many people in it. Take that into consideration before getting the needle.

Beyond big pharma, there are many players using the opportunity as a chance to obtain power, or to wield more power. Many selfish actors are willing to perpetuate the lie for these reasons.

4. “Outbreak” On File With CDN Gov’t

This fictional film (or predictive programming) was done a decade ago and Public Safety Canada makes them available for the public to watch. Interesting side note: this was on 2010, and wasn’t Stephen Harper the Prime Minister at the time?

Outbreak [videorecording (DVD)] : anatomy of a plague / written & directed by Jefferson Lewis ; produced by Kenneth Hirsch

Location
Public Safety Canada Library

Resource
DVDs

Call Number
RA 644 .S6 O97 2010d

Authors
Lewis, Jefferson, 1951-
Hirsch, Kenneth.
National Film Board of Canada.
Mongrel Media.
Office national du film du Canada.

Publishers
[Toronto] : Mongrel, 2010.
Description
1 videodisc (87 min) : sd., col. ; 12 cm. (DVD)

5. Tam’s Conflict Of Interest With WHO

They even used the same picture for both profiles.

Dr. Tam has served as an international expert on a number of World Health Organization committees and has participated in multiple international missions related to SARS, pandemic influenza and polio eradication.

This may be stretching it, but Tam’s profile as Chief Public Health Officer of Canada is misleading. It refers to her roles in a past tense, suggesting she no longer has any involvement in the World Health Organization. But that is simply not true. AS for the assigned role by the Federal Government:

The Chief Public Health Officer (CPHO) is the federal government’s lead public health professional. The CPHO is responsible for:

  • Providing advice to the Minister of Health and President of the Public Health Agency of Canada on health issues;
  • Working with other governments, jurisdictions, agencies, organizations, and countries on health matters;
  • Providing an annual report to the Minister on the state of public health in Canada for tabling in Parliament; and
  • Speaking to Canadians, health professionals, stakeholders, and the public about issues affecting the population’s health.

The CPHO is also accountable for or has delegated responsibilities for public health-related provisions of the Public Health Agency of Canada Act, the Quarantine Act, the Human Pathogens and Toxins Act and the Department of Health Act.

In an Emergency
In a public health emergency, such as an outbreak or natural disaster, the Chief Public Health Officer is responsible for:

  • Briefing and advising Canada’s Minister of Health, the President of the Public Health Agency and others as appropriate;
  • Working with counterparts in other departments, jurisdictions, and countries, as well as with experts and elected officials, to communicate with Canadians about how to protect themselves and their families;
  • Personally delivering public health information to Canadians via media appearances, public statements, updates to the Public Health Agency web site, and columns and public advertisements in daily and community newspapers;
  • Providing direction to Public Health Agency staff, including medical professionals, scientists, and epidemiologists, as they plan and respond to the emergency;
  • Leading daily national teleconferences as appropriate with federal government scientists and experts to share information and plan outbreak responses; and
  • Coordinating with jurisdictions through regular teleconferences with Canada’s provincial and territorial Chief Medical Officers of Health and others.

This all is fine and good, except holding a position with the World Health Organization at the same time is not in the public interest. In times where WHO offers poor advice, Tam would have to choose between rejecting that advice, or adopting it and running interference.

Although the details are enough to be an article by themselves, Tam has shown repeatedly that this conflict-of-interest is to the detriment of Canadians.

6. GAVI Archives Available

A shout out to @SomeBitchIKnow (that’s her handle, not me being rude), for sharing this gold mine of information from GAVI, the Global Alliance for Vaccines and Immunizations.

Library and News
https://archive.is/TBVgg

Human Papillomavirus Vaccine Support
https://archive.is/KBH9E

Low Prices Agreed For Human Papillomavirus Vaccine
https://archive.is/7oxDl

GAVI Pledging Conference 2011
https://archive.is/xsJC7

Pentavalent Vaccine — New and Underused
https://archive.is/K9uQt

Myanmar Children, Pentavlent & Measles
https://archive.is/8Hver

GAVI Gives LDS Church $1.5 Million
https://archive.is/fAyX2

2014 – US President Proposes $200M For GAVI
https://archive.is/U1zjk

2013 GAVI Archived Main Page
https://archive.is/gcfyH

GAVI – Funding and Finance Mechanisms
https://archive.is/EMUXm

Support For New & Underused Vaccines
https://archive.is/rYfKG

GAVI’s Partnership Model, Information
https://archive.is/w1a0N

Liberia, Country Hub For Vaccines
https://archive.is/vIzjx

Evaluation Advisory Committee
https://archive.is/1yCU4

Pneumococcal AMC Innovative Financing Model
https://archive.is/kCTsz

Donors Commit To Funding Milestone
https://archive.is/V2LIH

GAVI Board Members, Term Expiry
https://archive.is/UgfRu

Board Members, New Page
https://archive.is/VpNW

GAVI: A To E Glossary
https://archive.is/K3Ouo

GAVI: 2012 Partners’ Forum
https://archive.is/kDt7

Seth Berkley: CEO, Ex-Rockefeller
https://archive.is/pgzM

More On Seth Berkley: Ex Int’l AIDS Vaccine Initiative
https://archive.is/t6vg

2011 GAVI Announcements (German)
https://archive.is/Pid8

2012/2013 Countries Approved For Support
https://archive.is/Af1F

Mission Statement From GAVI
https://archive.is/yP4p

Country Co-Financing Commitments
https://archive.is/mO27

GAVI Pledging Conference, June 2011
https://archive.is/ouZg

Governing GAVI
https://archive.is/fTLs

Zimbabwe Launches Pneumococcal Vaccine
https://archive.is/FLqL

GAVI Welcomes Lower Drug Prices
https://archive.is/tGuX

GAVI Factsheets, Publications
https://archive.is/dWVE

GAVI, Vaccines, Return On Investment
https://archive.is/4z4E

When GAVI took down their site, they likely thought that the information they didn’t want saved would be lost. Not the case, as nothing is ever really erased.

7. The Coronavirus Rabbit-Hole

In a sense this is a prequel to the CV series coming out, though it’s a newer piece. Actually, Part 11 of the series (Ontario lobbying) is already up.

There isn’t just one person, one organization, or one fact to know. This planned-emic is a well coordinated and thought out attack on our livelihood. Know who is behind it, know who is being lobbied. There is so much that politicians and the media are not saying.

In fact, several pieces focus exclusively on the lobbying. If government officials are promoting mass vaccination, we should be asking why. Since they won’t answer truthfully, then check out who they have been talking to.

Much more still needs to be done.

CV #11: Pharma Lobbying In Ontario — Good Thing Bill 160 Was Never Implemented

Bill 160 passed Third Reading in the Ontario Legislature at the end of 2017. However, since it never received Royal Proclamation, it’s not officially law. This will become important soon.

Like so many pieces of legislation, it was packed so full that it was impossible to properly sort out.

  • Ambulance Act
  • Anti-Racism Act, 2017
  • Broader Public Sector Accountability Act, 2010
  • Child and Family Services Act
  • Child, Youth and Family Services Act, 2017
  • City of Toronto Act, 2006
  • Commitment to the Future of Medicare Act, 2004
  • Coroners Act
  • Drug and Pharmacies Regulation Act
  • Electronic Cigarettes Act, 2015
  • Excellent Care for All Act, 2010
  • Freedom of Information and Protection of Privacy Act
  • Healing Arts Radiation Protection Act
  • Health Care Consent Act, 1996
  • Health Facilities Special Orders Act
  • Health Insurance Act
  • Health Protection and Promotion Act
  • Health sector payment transparency act, 2017
  • Independent Health Facilities Act
  • Local Food Act, 2013
  • Local Health System Integration Act, 2006
  • Long-Term Care Homes Act, 2007
  • Medical Radiation and Imaging Technology Act, 2017
  • Medical Radiation Technology Act, 1991
  • Ministry of Health and Long-Term Care Appeal and Review Boards Act, 1998
  • Municipal Act, 2001
  • Occupational Health and Safety Act
  • Ontarians with Disabilities Act, 2001
  • Ontario Drug Benefit Act
  • Ontario Energy Board Act, 1998
  • Ontario Mental Health Foundation Act
  • Oversight of Health Facilities and Devices Act, 2017
  • Patient Restraints Minimization Act, 2001
  • Pay Equity Act
  • Personal Health Information Protection Act, 2004
  • Private Hospitals Act
  • Public Hospitals Act
  • Public Sector Labour Relations Transition Act, 1997
  • Public Sector Salary Disclosure Act, 1996
  • Quality of Care Information Protection Act, 2004
  • Regulated Health Professions Act, 1991
  • Residential Tenancies Act, 2006
  • Retirement Homes Act, 2010
  • Smoke-Free Ontario Act
  • Social Contract Act, 1993
  • Substitute Decisions Act, 1992
  • Tobacco Damages and Health Care Costs Recovery Act, 2009

Purpose
.
1 The purpose of this Act is to require the reporting of information about financial relationships that exist within Ontario’s health care system, including within health care research and education, and to enable the collection, analysis and publication of that information in order to,
.
(a) strengthen transparency in order to sustain and enhance the trust that patients have in their health care providers and in the health care system;
.
(b) provide patients with access to information that may assist them in making informed decisions about their health care;
.
(c) provide the Minister and others with information for the purposes of health system research and evaluation, planning and policy analysis; and
.
(d) provide for the collection, use and disclosure of personal information for these purposes.

Interpretation, “payor”
.
3 Any of the following persons is a payor for the purposes of this Act if the person provides a transfer of value to a recipient:
.
1. A manufacturer that sells a medical product under the manufacturer’s own name or under a trade-mark, design, trade name or other name or mark that is owned or controlled by the manufacturer and that fabricates, produces, processes, assembles, packages or labels the product, even if those tasks are performed by someone else on the manufacturer’s behalf.
.
2. A person who fabricates, produces, processes, assembles, packages or labels a medical product on behalf of a manufacturer described in paragraph 1.
.
3. A wholesaler, distributor, importer or broker that promotes or facilitates the sale of a medical product.
.
4. A marketing firm or person who performs activities for the purposes of marketing or promoting a medical product.
.
5. A person who organizes continuing education events for members of a health profession on behalf of a manufacturer described in paragraph 1.
.
6. A prescribed person or entity.
.
Reporting obligations
.
4 (1) Subject to subsection (2), a payor shall report to the Minister the information set out in subsection (5) with respect to the following transactions:
.
1. A transfer of value provided directly by a payor to a recipient.
.
2. A transfer of value provided indirectly by a payor to a recipient through an intermediary.

Schedule 4 is the most interesting part.

SCHEDULE 4
health sector payment transparency act, 2017

The Schedule enacts the Health Sector Payment Transparency Act, 2017.

The purpose of the Act, as set out in section 1, is to require the reporting of information about financial relationships that exist within Ontario’s health care system, including within health care research and education, and to enable the collection, analysis and publication of that information in order to, among other things, strengthen transparency. The Act requires that certain transactions be reported to the Minister who shall analyse and publish the information. The Act establishes a framework for inspections and other compliance mechanisms. The Act provides for periodic review by the Minister.

Bill 160 Never Actually Proclaimed

According to CanLII, Bill 160 wasn’t proclaimed (brought into force), as of May 29, 2019, which was a full 6 months after it had cleared in the Legislative Assembly. The Ontario Government “does” make reference to the passing of Bill 160, but adds in the all-important disclaimer: ONCE PROCLAIMED INTO FORCE

****Ford Never Implemented Bill 160***

Health.Sector.Payment.Transparency.Act20171123_Submission-on-Bill-160_IMC_Final
b160.accountability.ra_e

A law that would have made Ontario the first province in which drug companies were forced to publicly disclose their payments to doctors is in limbo with less than two months to go before the data collection was supposed to begin.

Premier Doug Ford’s Progressive Conservative government has not enacted the regulations that would bring into force the Health Sector Payment Transparency Act, legislation that was hailed as a major step toward openness in medical marketing when the former Liberal government passed it nearly a year ago.

Health Minister Christine Elliott’s office would not say whether the Tories intend to proceed with the transparency law or abandon it.

In the meantime, the legislation has been left to languish alongside other laws the Liberals passed but did not execute before they were swept out of office in June.

“We know, in many cases, the health sector did not feel that the prior government engaged in proper consultation when enacting legislation,” Hayley Chazan, the minister’s press secretary, said in an e-mailed statement that declined to answer specific questions about the transparency law. “That’s why our government is broadly consulting with partners in health care and reviewing all legislation that has not yet come into force as part of our efforts to develop a long-term transformational health strategy.”

The law would have led to the release of massive amounts of new data about how the pharmaceutical industry tries to influence the practice of medicine in the province.

How convenient it is that a law passed in 2017 was never actually implemented. This would have forced drug manufacturers and consultants to disclose how much money they had been spending in order to push their drugs to the public at large.

Ford claims (as did Wynne) that a delay is necessary in order to consult various parties and look for ways to best implement it. So, then why go through the time and expense of drafting and debating legislation BEFORE the consultations were done and the details worked out? Why is doing it AFTER the fact a better alternative?

Or, could this just be a way of “appearing” to clamp down on lobbyist influence, while still ensuring that is goes ahead nonetheless? Doesn’t seem like a populist thing to do.

Of course, this is nowhere near all of them. Does it paint a clearer picture? The Ontario Government is on the receiving end of lobbying by the drug industry. But because Bill 160 wasn’t implemented, we won’t know if any money has changed hands.

Could this be the real reason Bill 160 was never implemented? All of these lobbying records look back enough on the surface. However, if money changed hands in order for certain drugs to be approved, or be sold in certain places, it ups the sleaziness considerably.

Kathleen Wynne passed Bill 160 in late 2017. She could have easily implemented it. So could have Doug Ford when he took power. Both had majority governments.

Keep in mind, this is not an exhaustive list of the drug lobbying that is going on in the Ontario Legislature. There is much more, and the above is just a sample of it.

(1) https://www.ola.org/en/legislative-business/bills/parliament-41/session-2/bill-160
(2) https://www.ola.org/en/legislative-business/bills/parliament-41/session-2/bill-160#BK6
(3) https://www.canadianmanufacturing.com/manufacturing/apotex-pharmachem-produces-hand-sanitizer-250950/.
(4) http://archive.is/H5OBj
(5) https://lobbycanada.gc.ca/app/secure/ocl/lrs/do/vwRg?cno=452&regId=858242
(6) https://nationalpost.com/health/drug-companies-would-be-forced-to-reveal-payments-to-doctors-under-new-ontario-legislation
(7) http://archive.is/CRqts
(8) https://www.canlii.org/en/on/laws/stat/so-2017-c-25-sch-4/latest/so-2017-c-25-sch-4.html
(9) https://www.theglobeandmail.com/canada/article-ford-pcs-leave-drug-company-transparency-law-in-limbo/
(10) http://archive.is/g1NHC
(11) http://lobbyist.oico.on.ca/Pages/Public/PublicSearch/
(12) Health.Sector.Payment.Transparency.Act20171123_Submission-on-Bill-160_IMC_Final
(13) Bill 160 Accountability

CV #10: Pharma Lobbying Of AB Gov’t; Wellington Advocacy; Counsel Public Affairs; Others

1. Other Articles On CV “Planned-emic”

The rest of the series is here. Many lies, lobbying, conflicts of interest, and various globalist agendas operating behind the scenes. The Gates Foundation finances: the World Health Organization, the Center for Disease Control, GAVI, ID2020, John Hopkins University, Imperial College London, the Pirbright Institute, the British Broadcasting Corporation, and individual pharmaceutical companies. Also: there is little to no science behind what our officials are doing; they promote degenerate behaviour; the Australian Department of Health admits the PCR tests don’t work; the US CDC admits testing is heavily flawed; and The International Health Regulations are legally binding. See here, here, and here.

2. Important Links

(1) https://www.wellingtonadvocacy.com/
(2) http://archive.is/0x8cN
(3) https://www.linkedin.com/in/rachel-curran-a99258109/
(4) http://archive.is/lchjs
(5) https://counselpa.com/strategic-communications/
(6) http://archive.is/tBPaJ
(7) https://www.linkedin.com/company/counsel-public-affairs-inc-toronto-ontario/
(8) http://archive.is/r5Qg6
(9) https://edmonton.ctvnews.ca/we-won-t-wait-kenney-says-alberta-may-use-covid-19-tests-treatments-approved-by-other-countries-1.4896121?cache=yes%3FclipId%3D89680%3FclipId%3D373266%3FclipId%3D89680%2F5-things-to-know-for-thursday-october-31-2019-1.4663743
(10) http://archive.is/M1FOy
(11) https://www.albertalobbyistregistry.ca

3. Context For This Piece

Some of the lobbying at the Federal level has been published in earlier pieces on this site. However, this is not true at the Provincial level. The question that has to be asked is whether lobbying is playing a role in getting various Premiers to support the vaccination agenda.

The answer is yes, or at least it certainly looks like it. This article will focus on Alberta, now headed by Jason Kenney. Others will be addressed subsequently. Kenney is blatantly pro-vaxx, and people have to ask who is pulling the strings for this agenda.

Clearly, Wellington Advocacy and Counsel Public Affairs are not the only 2 groups lobbying the Alberta Government. But they are both very prominent.

Also noteworthy is that Kenney is a former Cabinet Minister in Stephen Harper’s Government. He is a twice-attendee of the Bilderberg meetings. Kenney has powerful connections.

4. Jason Kenney Wants Mass Vaccination

(From March 30, 2020 public announcement)

Jason Kenney, like the Federal Government, and other Premiers, supports the agenda for mass vaccination. Unlike the Feds, though, Kenney hasn’t (so far) said that it will be mandatory, but we will have to see what becomes of it.

EDMONTON — Prime Minister Justin Trudeau defended his government Tuesday after Alberta’s premier suggested Ottawa is dragging its feet on approving potential screening devices and treatments for COVID-19.

On Sunday, Jason Kenney tweeted that he had directed staff to consider using tests, vaccines or medications “that have been approved by the high standards of at least one credible peer country’s drug agency.”

That of course is just a clip from a broader article. Point is, Kenney seems on board with vaccinations. He doesn’t want Ottawa potentially slowing it down.

5. Wellington Advocacy, ex-PMO Staffers

What we do
Wellington Advocacy helps you build, run and win campaigns.
.
After a decade of working alongside Stephen Harper on the campaign trail and in office, our team is uniquely positioned to help you build government relations strategies, digital campaigns, stakeholder coalitions and blueprints to run.
.
Government Relations
Our team will work with you to build and deliver a concise and compelling presentation to government. Drawing on vast public policy and government experience, we ensure the right people hear your message at the right time.
.
Digital
Finding and winning over an audience is central to any successful campaign. We know how to identify and engage audiences and will help you build a bespoke digital strategy to capture the attention you need to deliver your message.

This lobbying firm was with Stephen Harper for more than a decade, and even played a role in the PMO (Prime Minister’s Office). They brag about having influence. Now, they lobby (current) Alberta Premier Jason Kenney. Keep in mind, that Kenney was Immigration Minister for much of his time in Harper’s Government. All of this reeks of a conflict-of-interest.

Wellington.1.Registered.Office.and.Directors
wellington.2.articles.of.incorporation
Wellington.3.change.to.director.information
Wellington.4.notice.of.return.filed

According to the Lobbying Registry of Alberta, Wellington Advocacy has lobbied the Alberta Government 53 times since May 2019. While certainly not all of their clients are drug companies, several of as late, are.

DATE
LOBBYIST
CLIENT
SENIOR OFFICER

23-Apr-2020
Wellington Advocacy Inc.
Triple M Housing
Nick Koolsberge

23-Apr-2020
Wellington Advocacy Inc.
Spartan Bioscience Inc
Nick Koolsbergen

19-Apr-2020
Wellington Advocacy Inc.
AMD Medicom Inc
Nick Koolsbergen

22-Mar-2020
Wellington Advocacy Inc.
Bayshore Healthcare LTD
Nick Koolsbergen

22-Mar-2020
Wellington Advocacy Inc.
Shoppers Drug Mart
Nick Koolsbergen

6. Counsel Public Affairs, Inc.

Healthcare
Our team has extensive experience working across the health care sector, from hospital operations and broader health care industry governance, to service providers and product manufacturers, and to the regulated health professionals who support the system. Counsel has advocated on behalf of doctors, nurses, hospitals, pharmaceutical companies, pharmacies, medical device manufacturers, healthcare associations and patient groups on a wide range of mandates.

LOBBYING
Engaging decision makers with a powerful, persuasive and fact-based position is the key to success. With decades of experience working at all levels of government, we know how to effectively bridge the gap between those inside and outside of the political sphere to find solutions for your most important issues.
.
POLICY DEVELOPMENT
We know how government weighs options, evaluates impacts, and makes choices. We understand the policy process and how your organization can intervene effectively. We’ll help to ensure the facts are laid out, your case gets in front of the right people, and the policy implications are clear.
.
STAKEHOLDER AND INFLUENCER ENGAGEMENT
Skilled and targeted stakeholder management involves both recruiting allies and minimizing opposition. We can help you identify, track, and influence stakeholders.

Their LinkedIn page is filled with countless examples of Counsel Public Affairs attempting to control political narratives. Members have ties to many political parties, so they really are playing all sides.

11-Apr-2020
Counsel Public Affairs Inc.
Emergent BioSolutions Canada Inc. (formerly Adapt Pharma Canada Ltd.)
Philip Dew

Counsel does have offices in other provinces, and connections to many political parties.

7. Registered Lobbying Reports

24-Apr-2020
AstraZeneca Canada Inc.
Jane Chung

23-Apr-2020
Wellington Advocacy Inc.
Triple M Housing
Nick Koolsbergen

22-Apr-2020
Stosic & Associates Ltd.
Mint Pharmaceuticals Inc.
Aleksandar Stosic

16-Apr-2020
Becton Dickinson Canada Inc
Gregory Miziolek

16-Apr-2020
Hill + Knowlton Strategies
3M Canada Company
Sheila Wisniewski

15-Apr-2020
Global Public Affairs
Applied Pharmaceutical Innovation
Randy Pettipas

15-Apr-2020
Novartis Pharmaceuticals Canada Inc.
Christian Macher

11-Apr-2020
Counsel Public Affairs Inc.
Emergent BioSolutions Canada Inc. (formerly Adapt Pharma Canada Ltd.)
Philip Dewan

09-Apr-2020
Lundbeck Canada Inc.
Peter Anastasiou

09-Apr-2020
Rothmans, Benson, & Hedges
Peter Luongo

07-Apr-2020
Pfizer Canada ULC
Cole Pinnow

07-Apr-2020
Merck Canada Inc.
Anna Van Acker

06-Apr-2020
Alberta Pharmacists’ Association
Margaret Wing

01-Apr-2020
Janssen Inc.
Jorge Bartolome

This is of course not an exhaustive list of who has been lobbying the Government in Alberta. Nor is health the only topic that gets lobbied for.

But it is interesting to see how many interested parties are coming forward. And “interested” refers to those who will be able to make money off such a vaccine or other remedy. When there is a lot of money at stake, people must always be wondering who is possibly pulling the strings.

One thing seems clear though: the Alberta Government won’t be waiting around for Ottawa to make a decision. Whether AB ultimately decides to go the route of mass vaccinations is unknown. However, there are companies who would profit greatly from it.

It also can’t be understated the conflict of interest that arises when lobbyists — many of whom have ties to government officials — start lobbying those officials on matters that are not in the best interests of the people. Much like Crestview Strategy and many more, Wellington Alliance and Counsel Public Affairs rely on their personal connections to pass initiatives that their clients pay for.

CV #7(B): Raj Saini Introduced M-132, Lobbied By Big Pharma

Saini is listed many times in connection with the Lobbying Commissioner’s Office. Many of those communications reports are with pharmaceutical companies who are lobbying him.

Saini is a board member for the Canadian International Council. Here are the main founders that is lists. Some of these names should be familiar.

1. Other Articles On CV “Planned-emic”

The rest of the series is here. Many lies, lobbying, conflicts of interest, and various globalist agendas operating behind the scenes. The Gates Foundation finances: the World Health Organization, the Center for Disease Control, GAVI, ID2020, John Hopkins University, Imperial College London, the Pirbright Institute, the British Broadcasting Corporation, and individual pharmaceutical companies. Also: there is little to no science behind what our officials are doing; they promote degenerate behaviour; the Australian Department of Health admits the PCR tests don’t work; the US CDC admits testing is heavily flawed; and The International Health Regulations are legally binding. See here, here, and here.

2. Important Links

(1) https://rsaini.liberal.ca/
(2) http://archive.is/dz8Fx
(3) https://www.therecord.com/news-story/6058693-newly-elected-mp-raj-saini-ready-to-give-back-to-kitchener/
(4) http://archive.is/3U1YO
(5) https://openparliament.ca/debates/2017/9/25/raj-saini-1/
(6) http://archive.is/JFfTE
(7) https://thecic.org/about/governance/
(8) http://archive.is/YqLj5
(9) https://www.medicalinnovationxchange.com/
(10) http://archive.is/u3gUp
(11) https://www.globenewswire.com/news-release/2020/01/10/1969154/0/en/Medtech-CEO-Armen-Bakirtzian-paying-it-forward-by-creating-incubator-to-keep-IP-in-Canada-foster-Canadian-talent.html
(12) http://archive.is/TMp6H
(13) https://www.ept.ca/2020/01/tech-incubator-created-to-drive-medical-innovation/
(14) http://archive.is/vNeAz

3. Raj Saini’s LPC Profile

A proud resident of Kitchener-Waterloo, Raj Saini has owned and operated an award-winning small business for nearly 20 years. His success as a small business owner comes from his focus on helping people achieve their health goals using evidence-based protocols to enable healing and encourage healthy lifestyles.
.
A committed and active supporter of local organizations, Raj works tirelessly to engage his community in politics and international affairs. He is a proud Rotarian of many years, a board member of the Canadian International Council, Waterloo Region branch and a long-time champion of Liberal values. He is passionate about improving the local economy, creating jobs and promoting the health and well-being of Kitchener Centre’s residents through intelligent, fiscally responsible environmental and health policy.
.
Raj earned his Bachelors of Science in Chemistry from the University of Toronto, and a Bachelors of Science in Pharmacy from Boston’s Northeastern University.

The above is taken directly from his profile. Let’s get into the issues that exist here, and why they are a problem.

4. Saini Co-Owned A Pharmacy

In 2017, Saini pandered in Parliament on the issue of World Pharmacist’s Day. No shocker, given his personal and professional stake in the industry.

KITCHENER — As a pharmacist, Raj Saini says he learned a few things about serving all segments of society. After getting elected to the House of Commons, he wants to keep doing that, but with a larger customer base — about 102,433 people, to be exact.

That’s the most recent census information available for Kitchener Centre, the riding that Liberal MP-elect Saini will represent after winning last Monday’s federal election in his first run at public office.

As the co-owner of the independent Greenbrook Pharmacy, it should come as no surprise that nothing tops Saini’s list of priorities as he heads to Ottawa more than the need for a national pharmacare policy.

Fewer and fewer Canadians have benefits that cover the costs of prescription drugs and those rising out-of-pocket medicine expenses are the missing link in the country’s universal health care coverage, he said.

Raj Saini is a pharmacist, and co-owns one as well. While there is nothing wrong with this (and is admirable) the strange connections shown later are a cause for concern.

In 2019, Saini rehashed the same old Liberal campaign promise for universal drug coverage. In all fairness though, the LPC has been campaigning on it since 1993 and has never delivered on it.

5. Saini Lobbied By GAVI In 2019

Jason Clark, who works for the firm Crestview Strategy, lobbied Saini on March 8, 2018, on behalf of GAVI. GAVI is the Gates-funded Global Alliance for Vaccines and Immunizations. This was after Saini had introduced M-132, and prior to the Committee hearings in Parliament.

6. Other Pharma Lobbying MP Saini

All of these records can be verified by searching Raj Saini’s name in the Office of the Lobbying Commissioner of Canada. This is by no means all of the records, but shows a pretty good indication of who he has been speaking with.

Remember, it’s legal as long as it’s documented.

7. Canadian International Council

canadian.intl.council.1.bylaws
canadian.intl.council.2.certificate.of.continuance
canadian.intl.council.3.change.of.address
canadian.intl.council.4.change.of.directors

About
What makes the CIC unique is our network of 15 branches across seven provinces. This gives us a presence, in local communities, that is unparalleled in Canadian global affairs.
.
Thanks to this presence, Canadians from all walks of life, all ages, political opinions, and professions can discuss and learn about international affairs and contribute their views. In reflecting on the ideas and interests of a broad constituency of Canadians, the CIC demonstrates that our country’s foreign policy is not an esoteric concern of experts but benefits from direct citizen involvement.
.
As thousands of people join in an ongoing series of events and online discussions, the whole is greater than the sum of its parts. The result is a national conversation on our country’s role in the world.
.
We engage our members and the public to join the conversation through three types of activity: they can attend events, read our research and can share their opinions online.

Saini’s profile states that he is a Director at this organization (the Waterloo Branch). However, in searching him on the internal search, it doesn’t appear that he has contributed any publications to the organizations.

It’s interesting though: to be a Director at this group, which is looking for global solutions (on many issues). Saini introduced M-132, which will increase research and distribution of pharmaceuticals both in Canada and abroad. Certainly this is consistent with CIC’s agenda, but hard to tell if it is influencing the motion.

8. MP Saini Introduced M-132 In 2017

For a speech on passing M-132.
The text is below

Motion Text
That the Standing Committee on Health be instructed to undertake a study on ways of increasing benefits to the public resulting from federally funded health research, with the goals of lowering drugs costs and increasing access to medicines, both in Canada and globally; and that the Committee report its findings and recommendations to the House no later than one year from the time this motion is adopted.

Submissions Lodged
hesa.Structural.Genomics.Consortium.submission
hesa.Medicines.Patent.Pool.2018
hesa.Doctors.Without.Borders.2018
hesa.Canadian.Institutes.Of.Health.Research.2018
hesa.Fowke.Keith.University.Manitoba.2018
hesa.University.College.London.drug.prices.2018
hesa.Drugs.For.Neglected.Diseases.Initiative.2018
hesa.Moon.Suerie.2018
hesa.Yusuf.Salim.mcmaster
hesa.FIND.tb.alliance.gates.gavi.unitaid
hesa.Vlassoff.Carol.2018
hesa.Universities.Allied.For.Essential.Medecines.2018
hesa.Bruyere.Research.Institute.2018
hesa.Molyneux.David.2018

Dates Of Meetings
Thursday, September 27, 2018
Hesa.2018.September.27.evidence.transcript

Tuesday, October 2, 2018
Hesa.2018.October.2.evidence.transcript

Thursday, October 4, 2018
Hesa.2018.October.4.evidence.transcript

Tuesday, October 16, 2018
Hesa.2018.October.16.evidence.transcript

Thursday, October 18, 2018
Hesa.2018.October.18th.evidence.transcript

Tuesday, October 23, 2018
Hesa.2018.October.23.evidence.transcript

Thursday, October 25, 2018
Hesa.2018.October.25.evidence.transcript

REPORTS ISSUED
hesa.november.2018.report.to.parliament
hesa.government.response.march.2019

HOW THE FEDERAL GOVERNMENT COULD FOSTER INNOVATION IN PHARMACEUTICAL RESEARCH AND DEVELOPMENT IN CANADA AND GLOBALLY
.
Witnesses suggested to the Committee that the federal government could address these challenges by increasing its investments in health research; promoting the creation of innovative alternative models of pharmaceutical R&D; and establishing strategic priorities for pharmaceutical R&D in line with both domestic and international population health needs.

(ii) Repurposing of Existing Drugs Dr. Keith Fowke, Professor, Department of Medical Microbiology and Infectious Diseases, University of Manitoba, told the Committee that federal funding of research focusing on examining ways to repurpose existing drugs that are safe, affordable and globally available to treat new conditions is another possible approach of reducing the costs of drug development, while ensuring affordable access to treatments. He explained to the Committee that his CIHR-funded research on HIV/AIDS examined the role that aspirin could play in preventing the spread of infection by reducing inflammation in cells in the genital tract that are susceptible to the HIV virus. His research showed that aspirin reduced the number of HIV target cells in the genital tract by 35%, which is paving the way for clinical trials in this area. Dr. Fowke recommended that CIHR continue to support innovative fundamental research that focuses on the repurposing of existing widely available generic drugs for the treatment of new conditions, an approach that reduces timelines and costs for R&D as these medications already exist

C. Develop a Strategic Framework for Federally Funded Health Research in Canada and Abroad
Finally, the Committee heard from both Drs. Nickerson and Yusuf that the federal government needs to develop a strategic framework that identifies priorities for health research funding that focuses on population health needs both in Canada and abroad. Though various federal government departments and agencies, including CIHR, the Public Health Agency of Canada and Global Affairs Canada have proposed priorities for federal health research funding both nationally and internationally, witnesses indicated that there is a need to review and better coordinate health research priorities across government to determine whether they are meeting population health needs. This priority setting would help identify areas where the federal government should target its investments in pharmaceutical R&D, which would leverage Canadian expertise across governments, universities, industry and civil society.

It cannot be overemphasized that these reports focus not only on cheap drugs for Canadians. They also are directed to the world at large. Presumably they will be sold at low rates, but since it’s not specified, they could be donated. Those are quotes from the November 2018 report that was released.

9. MP Saini Attended MIX Grand Opening

KITCHENER, ON, Jan. 10, 2020 (GLOBE NEWSWIRE) — Medical Innovation Xchange (MIX), Canada’s first industry-led hub for medtech startups, celebrated its official launch and ribbon-cutting ceremony on Friday, January 10, 2020 at its Kitchener headquarters. Mr. Simon Kennedy, Deputy Minister, Innovation, Science & Economic Development provided the keynote address on what infrastructure is required to help retain and successfully scale Canadian medtech startups. Honoured guests included Kitchener Mayor Berry Vrbanovic, Member of Parliament Raj Saini, Member of Parliament Tim Louis, and industry leaders including prominent medtech CEOs, investors, hospital administrators, and government officials.

MIX, spearheaded in June 2019 by Intellijoint Surgical CEO Armen Bakirtzian, joins the powerful community within the Toronto-Waterloo Innovation Corridor to offer Canadian medtech companies an environment to grow locally and go to market globally. MIX Residents have a unique opportunity to retain ownership in early stages and succeed by leveraging MIX resources to avoid early stage pitfalls and post-prototype growing pains. The successes of Intellijoint Surgical, which celebrated its landmark 10,000th surgery in April of last year, and other successful Canadian medtech strategic advisors, help illuminate the path to bootstrapping as an alternative to acquisition by, for example, global medical device and pharmaceutical companies or packing up and moving operations to the United States.

“We are experiencing a tech boom right across our region,” adds Tim Louis, MP for Kitchener Conestoga. “We excel at IP development, and have a global reputation in high-tech manufacturing – from automotive to aerospace. But we understand that more must be done to cultivate local successes. When IP leaves the country, we miss out on future opportunities, as well as the potential spillover effect from high-tech research. MIX will certainly help to address some of those gaps.”

Since the June 2019 announcement of its founding, MIX has already received dozens of inquiries from interested companies seeking to become part of the community. This will ensure Bakirtzian meets his commitment to fill the incubator’s office space with mature startups that would most benefit from peer-to-peer information exchanges over the course of their minimum 18-24 month occupancy. “We are committed to helping ‘grow our own’” says Bakirtzian, “and it starts with ensuring the most promising medtech startups have a home here at 809 Wellington Street where they can thrive and scale.”

MIX, the Medical Innovation Exchange, had it’s grand opening, on January 10, 2020. MP Saini was one of those in attendance. Since its launch, MIX has focused it’s services on the coronavirus epidemic, which happened very shortly afterwards. What a great, but coincidental timing this is. Here is another article covering the launch.

Bakirtzian and MIX’s inaugural Residents want to galvanize these realities for the medtech space and their many peers in the Kitchener-Waterloo area. Their vision also includes addressing tough questions about healthcare procurement policies, which impact the domestic healthcare market, and channels to access more mature sources of funding. They are keenly aware of the immediate and broader impact of their work.

“Canada is a place where innovation thrives – especially here in the Kitchener-Waterloo region.” says Raj Saini, MP for Kitchener Centre. “We offer one of the best economies in the world for new business ventures as well as small and medium enterprises. And medtech is an area rich in intellectual property — something Canadians lead at developing. But we need to improve at commercialization. Of patents filed in the past two years, 60% ended up with global companies within a year.”

“We are experiencing a tech boom right across our region,” adds Tim Louis, MP for Kitchener Conestoga. “We excel at IP development, and have a global reputation in high-tech manufacturing – from automotive to aerospace. But we understand that more must be done to cultivate local successes. When IP leaves the country, we miss out on future opportunities, as well as the potential spillover effect from high-tech research. MIX will certainly help to address some of those gaps.”

MIX, the Medical Innovation Xchange, doesn’t actually do any research itself. Instead, it is a hub, or a place of centralization for others to research. Although this is just starting out, it will be very interesting to see where things lead.

10. Waterloo Corporate Welfare

Today, Raj Saini, Member of Parliament for Kitchener Centre, on behalf of the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development and Minister responsible for FedDev Ontario, announced a contribution of $2.57 million for Nicoya to scale up operations and accelerate growth into new markets.

“This FedDev Ontario investment in Nicoya is wonderful news for Waterloo Region. Twenty-nine good-paying, highly-skilled jobs will be added in our community, and our thriving biotechnology and health sciences cluster will be strengthened. Our government is committed to ensuring the competitiveness of our region both at home and abroad.”
– Raj Saini, Member of Parliament for Kitchener Centre

Off topic, but Saini handed out $2.57 million to create 29 jobs, or more than $88,000/per job. Great use of taxpayer money.

11. Issue With Saini’s Connection

Raj Saini is a licensed pharmacist, but he has also been lobbied by drug companies (among others) for his entire time in office. One of those parties was GAVI, the Global Vaccine Alliance that is largely financed by Bill Gates and his Foundation. On the surface at least, these look like a clear conflict of interest.

Saini introduced M-132, to get the House of Commons Standing Committee on Health to study ways to increase pharmaceutical research. The people who appeared before the Committee and give submissions have vested interests in seeing this go ahead.

M-132 could be totally coincidental, but consider how it looks. The motion is introduced in 2017, the hearings are in the fall of 2018, and the recommendations are adopted in March 2019. Later that year, Event 201 would be held and the coronavirus “pandemic” would be unleashed.

How convenient it is that the Parliamentary hurdles were cleared in time for drug researching to be advanced.

%d bloggers like this: